JP2002530268A5 - - Google Patents

Download PDF

Info

Publication number
JP2002530268A5
JP2002530268A5 JP2000542326A JP2000542326A JP2002530268A5 JP 2002530268 A5 JP2002530268 A5 JP 2002530268A5 JP 2000542326 A JP2000542326 A JP 2000542326A JP 2000542326 A JP2000542326 A JP 2000542326A JP 2002530268 A5 JP2002530268 A5 JP 2002530268A5
Authority
JP
Japan
Prior art keywords
pyrazin
ethyl
methyl
oxamoylpyrrolo
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000542326A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002530268A (ja
JP4412521B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP1999/001670 external-priority patent/WO1999051605A1/en
Publication of JP2002530268A publication Critical patent/JP2002530268A/ja
Publication of JP2002530268A5 publication Critical patent/JP2002530268A5/ja
Application granted granted Critical
Publication of JP4412521B2 publication Critical patent/JP4412521B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000542326A 1998-03-31 1999-03-31 sPLA2阻害作用を有するピロロ[1,2−a]ピラジン誘導体 Expired - Fee Related JP4412521B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP8599798 1998-03-31
JP10-85997 1998-08-31
JP24473598 1998-08-31
JP10-244735 1998-08-31
PCT/JP1999/001670 WO1999051605A1 (en) 1998-03-31 1999-03-31 PYRROLO[1,2-a]PYRAZINE sPLA2 INHIBITOR

Publications (3)

Publication Number Publication Date
JP2002530268A JP2002530268A (ja) 2002-09-17
JP2002530268A5 true JP2002530268A5 (cg-RX-API-DMAC7.html) 2009-11-12
JP4412521B2 JP4412521B2 (ja) 2010-02-10

Family

ID=26427020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000542326A Expired - Fee Related JP4412521B2 (ja) 1998-03-31 1999-03-31 sPLA2阻害作用を有するピロロ[1,2−a]ピラジン誘導体

Country Status (11)

Country Link
US (1) US6407104B1 (cg-RX-API-DMAC7.html)
EP (1) EP1066290A1 (cg-RX-API-DMAC7.html)
JP (1) JP4412521B2 (cg-RX-API-DMAC7.html)
KR (1) KR20010042307A (cg-RX-API-DMAC7.html)
CN (1) CN1303384A (cg-RX-API-DMAC7.html)
AU (1) AU3054399A (cg-RX-API-DMAC7.html)
BR (1) BR9909345A (cg-RX-API-DMAC7.html)
CA (1) CA2326522A1 (cg-RX-API-DMAC7.html)
HU (1) HUP0102981A3 (cg-RX-API-DMAC7.html)
NO (1) NO20004881L (cg-RX-API-DMAC7.html)
WO (1) WO1999051605A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69931963D1 (de) * 1998-10-14 2006-07-27 Shionogi & Co Spla2-inhibitoren zur behandlung von ischämischen reperfusionsschäden
JP4636521B2 (ja) 1999-07-19 2011-02-23 塩野義製薬株式会社 sPLA2阻害作用を有する三環系化合物
US6787545B1 (en) 1999-08-23 2004-09-07 Shiongi & Co., Ltd. Pyrrolotriazine derivatives having spla2-inhibitory activities
AU7559600A (en) * 1999-10-15 2001-04-23 Shionogi & Co., Ltd. V type and/or x type spla2 inhibitors
WO2001036420A1 (en) * 1999-11-15 2001-05-25 Shionogi & Co., Ltd. Tricyclic azaindolizine derivatives having an spla2- inhibiting effect
WO2002000256A1 (fr) 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Remedes contre la cirrhose
AU2001267823A1 (en) * 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Compounds exhibiting x-type spla2 inhibiting effect
AUPQ876400A0 (en) * 2000-07-14 2000-08-03 University Of Queensland, The Compositions and method of using them
JP2004505982A (ja) * 2000-08-04 2004-02-26 イーライ・リリー・アンド・カンパニー 新規なsPLA2インヒビター
TWI314457B (cg-RX-API-DMAC7.html) * 2001-03-19 2009-09-11 Shionogi & Co
US6730694B1 (en) 2001-07-20 2004-05-04 Eli Lilly And Company sPLA2 inhibitors
DE10155727A1 (de) * 2001-11-13 2003-05-28 Morphochem Ag Serin Protease Inhibitoren
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
US7345178B2 (en) * 2005-08-04 2008-03-18 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
TW200916472A (en) * 2007-06-20 2009-04-16 Sirtris Pharmaceuticals Inc Sirtuin modulating compounds
CN107233337A (zh) 2009-04-29 2017-10-10 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法
CN105622616A (zh) * 2016-02-25 2016-06-01 上海雅本化学有限公司 一种4-氯吡咯并嘧啶的制备方法
US20250129010A1 (en) * 2021-09-17 2025-04-24 Mitsui Chemicals, Inc. Method for producing (meth)acrylamide compound

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109311A0 (en) 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
EP1950200B1 (en) 1994-04-01 2012-01-11 Eli Lilly And Company [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor
US5641800A (en) 1994-07-21 1997-06-24 Eli Lilly And Company 1H-indole-1-functional sPLA2 inhibitors
US6645976B1 (en) * 1994-07-21 2003-11-11 Eli Lilly And Company Indolizine SPLA2inhibitors
US6214876B1 (en) 1994-07-21 2001-04-10 Eli Lilly And Company Indene-1-acetamide sPLA2 inhibitors
IL124871A (en) 1995-12-13 2002-04-21 Lilly Co Eli Naphthyl glyoxamides and medicinal preparations containing them, as inhibitors of sPLA2
DE69614232T2 (de) 1995-12-13 2002-01-10 Eli Lilly And Co., Indianapolis Naphthyl-Acetamide als sPLA2-Inhibitoren
KR20000049210A (ko) 1996-10-30 2000-07-25 피터 지. 스트링거 치환된 트리시클릭류
US6353128B1 (en) 1996-12-03 2002-03-05 Eli Lilly And Company Phenyl acetamides as sPLA2 inhibitors
US5916922A (en) 1996-12-03 1999-06-29 Eli Lilly And Company Phenyl glyoxamides as SPLA2 inhibitors
ID18983A (id) 1996-12-04 1998-05-28 Lilly Co Eli Pirazola sebagai inhibitor sekresi fosfolipase a2 non-pankreas pada manusia
US5919774A (en) 1996-12-10 1999-07-06 Eli Lilly And Company Pyrroles as sPLA2 inhibitors
TW455581B (en) 1997-06-26 2001-09-21 Lilly Co Eli Process for preparing 4-substituted-1H-indole-3-glyoxamides

Similar Documents

Publication Publication Date Title
EP1491543B1 (en) Intermediate compounds for the preparation of imidazo-pyridine derivates
RU2528340C2 (ru) ПОЛУЧЕНИЕ ДИГИДРОТИЕНО[3,2-d]ПИРИМИДИНОВ И ПРОМЕЖУТОЧНЫХ ПРОДУКТОВ, ПРИМЕНЯЮЩИХСЯ ДЛЯ ИХ СИНТЕЗА
JP5318037B2 (ja) ピリミジン化合物を製造するための方法
CN107849037A (zh) 用于治疗和预防乙型肝炎病毒感染的新的三环4‑吡啶酮‑3‑甲酸衍生物
JP2007510646A5 (cg-RX-API-DMAC7.html)
ES2365073T3 (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparación y su aplicación en terapéutica.
CN1232463A (zh) 吡唑并吡啶基哒嗪酮衍生物及其制备方法
WO2007032466A1 (ja) 複素環化合物、その製造方法並びに用途
CA2547347C (en) Diazaindole-dicarbonyl-piperazinyl antiviral agents
JP2001504513A (ja) 4,5−ジアミノピリミジン誘導体およびその製造方法
JP2004518739A (ja) 抗炎症剤として有用なヘテロアリール置換尿素化合物の合成方法
JP2002037787A (ja) [1,2,4]トリアゾロ[1,5−c]ピリミジン誘導体の製造法
KR20010042307A (ko) 피롤로[1,2-a]피라진 sPLA2 억제제
JP2590797B2 (ja) イミダゾインドリジン誘導体及びその製法
CA2539444A1 (en) Hexa- and octahydro-pyrido[1,2-a]pyrazine derivatives with nk1 antagonistic activity
JP4208464B2 (ja) ナフチリジン−3−カルボン酸誘導体の製造法
JP4208463B2 (ja) キノロンカルボン酸誘導体の製造に関する中間体
EP2421864B1 (fr) DERIVES DE 1-PYRAZOLO[4,3-c]ISOQUINOLEINES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
EP2307401A2 (fr) Derives anticancereux de 4-oxo-1,4-dihydro-quinoline, leur preparation et leur application en therapeutique
JP2006117647A (ja) ハロゲノピラゾロピリジンピリダジノン誘導体とその付加塩及びそれを有効成分とするpde阻害剤
US6355663B1 (en) Substituted isoxazolylthiophene compounds
US20040152897A1 (en) Synthesis of indolizines
JPH03218377A (ja) アゾール誘導体及びそれらを有効成分とする抗潰瘍剤
KR102678127B1 (ko) 신규한 퀴논 유도체
EA002119B1 (ru) Способ получения 4-замещенных-1н-индол-3-глиоксамидов